Nuvama delivers another quarter of diversified growth; Q2 PAT up 26% YoY to ₹319 Cr

Nuvama Wealth Management Limited (NSE, BSE: NUVAMA), one of India’s leading wealth management companies, announced its financial results for the quarter and half year ending 30th September 2026.

Nuvama Group continued to deliver strong and diversified growth in Q2 and H1 FY27, underpinned by the strength of its integrated wealth management platform. Operating profit grew 26% YoY to ₹319 Cr in Q2 FY27 while H1 FY27 rose 21% YoY to ₹625 Cr.

Wealth Management continued its track record of consistent compounding, with profits growing 22% YoY in Q2 and net flows reaching record levels. Asset Services maintained strong momentum, while Capital Markets delivered a healthy performance supported by a diversified revenue mix. Reflecting continued client confidence, client assets reached ₹5.5 trillion, up 25% YoY, while MPIS and ARR client assets across Nuvama Wealth and Private increased 27% YoY to nearly ₹1.1 trillion.

Commenting on the performance Ashish Kehair, MD & CEO of Nuvama Group said, “We delivered another quarter of strong performance, with Q2 operating profits growing       26% YoY and RoE remaining strong at ~29%. Wealth Management continued its track record of consistent compounding with record net flows, Asset Services sustained strong momentum, and Capital Markets delivered a healthy performance despite a softer market environment.

While we are pleased with our progress, we remain in the early innings of a much larger opportunity. The structural shifts underway are expanding both the size and depth of the addressable market across each of our businesses.

We believe Nuvama is uniquely positioned to benefit from these trends. Over the years, we have built scaled and profitable franchises across our business segments. While each segment is independently strong, the real advantage lies in how they work together. The synergies create a powerful ecosystem that is difficult to replicate. We believe the full value of this integrated platform is only beginning to emerge.

At the heart of this franchise are our people. Our ability to attract, develop and retain high-quality talent remains one of our most important competitive advantages. As we look ahead, we remain focused on building an institution that delivers enduring value for clients, employees and shareholders alike."

Key Highlights

Wealth Management

Revenues: ₹501 Cr in Q2, grew by 14% YoY and ₹948 Cr in H1 FY27, grew by 16% YoY

PBT: ₹184 Cr in Q2, grew by 22% YoY and ₹332 Cr in H1 FY27, grew by 21% YoY

Client Assets: Stood at ₹3,71,129 Cr as at end of Q2, grew by 16% YoY

Nuvama Wealth:

Revenues: ₹275 Cr in Q2, grew by 14% YoY, and ₹525 Cr in H1 FY27, grew by             13% YoY, driven by sustained momentum in MPIS and growth in NII

PBT: ₹102 Cr in Q2, grew by 21% YoY and ₹191 Cr in H1 FY27, grew by 20% YoY, supported by operating leverage, with cost-to-income ratio improving by 200 bps YoY to 63% in Q2

Net flows: Delivered highest-ever quarterly MPIS NNM of ₹3,289 Cr. H1 NNM stood at ₹6,333 Cr, equivalent to 16% of opening MPIS assets

Nuvama Private:

Revenues: ₹226 Cr in Q2, grew by 15% YoY and ₹424 Cr in H1 FY27, grew by 20% YoY driven by strong growth in ARR revenues. ARR revenues grew 60% YoY in Q2

PBT: ₹82 Cr in Q2, grew by 24% YoY and ₹141 Cr in H1 FY27, grew by 23% YoY

Net flows: Delivered highest-ever quarterly ARR NNM of ₹4,986 Cr. H1 NNM stood at ₹ 6,068 Cr, equivalent to 11% of opening ARR assets

 Asset Management

Management fee: ₹17 Cr in Q2, lower by 2% YoY and ₹39 Cr in H1 FY27, up 11% YoY

Closing AUM: Stood at ₹12,000 Cr, grew by 1% YoY

Received SEBI’s approval to launch Specialized Investment Fund platform, Numa SIF, and offer SIF products under the platform

 Asset Services and Capital Markets

Revenues:

Asset Services: ₹245 Cr in Q2, higher by 53% YoY and ₹504 Cr in H1 FY27, higher by 43% YoY

Capital Markets: ₹175 Cr in Q2, higher by 9% YoY and ₹357 Cr in H1 FY27, higher by 5% YoY

PBT: ₹259 Cr in Q2, grew by 34% YoY and ₹527 Cr in H1 FY27, grew by 26% YoY

Client Assets (Asset Services): ₹1,63,835 Cr as at end of Q2, grew by 55% YoY

Comments

Post a Comment

Popular posts from this blog

A graphic novel about Anglo-Indian heritage with stunning illustrations

Image
The launch event for The History of Anglo-Indians: A Graphic Novel, a profound exploration of heritage, identity, and untold stories, was held on Saturday, August 8, 2026, at the C.P. Arts Convention Centre on Eldams Road in Chennai. The evening featured Dr. Oscar C. Nigli, the Senior National Vice-President of the All-India Anglo-Indian Association, as the esteemed special guest. Dr. Nigli is also a former Dean and Professor at Loyola College in Chennai, as well as a Former Anglo-Indian Member of the Legislative Assembly in Tamil Nadu. Attendees were treated to an insightful presentation by Keith Butler, who shared the research and creative journey behind The History of Anglo-Indians, followed by a discussion with the author. The graphic novel is brought to life by the stunning illustrations of Harry MacLure, a talented writer, cartoonist, artist, and comic book illustrator based in Chennai. MacLure is well known for his role as the editor of Anglos In The Wind, the longest-running ...
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more

Anglo-Indian National President Dr. Roy Rozario's Appeal to TN State Chief Minister C.Joseph Vijay

Image
Anglo-Indian Suburban Front held a significant press conference in Perambur on October 31, 2026. During this meeting, Dr. A. Roy Rozario, Founder and President of the Anglo-Indian Suburban Front, addressed several pressing issues faced by the Anglo-Indian community. One key concern highlighted was the urgent need for the restoration of a reserved seat for Anglo-Indian students in government engineering colleges in Tamil Nadu.     As there is no case pending at present in any Court, the Tamil Nadu State Government is free to restore the Reservations, added Dr.A.Roy Rozario Dr. A. Roy Rozario, who is also the National President of the Anglo-Indians Welfare Federation of India for Anglo-Indians of 7 States had also discussed the classification of the Anglo-Indian community under the Other Backward Classes (OBC) category in Tamil Nadu, emphasizing that this was a step similar to what Kerala adopted in 1993. This classification is supported by the findings of the September 2...
Read more